BNOEF

Bionomics Ltd.

 
Ordinary Shares International Reporting
OTCQX International
Verified Company Profile 4/18/2017
Contact Info
  • 31 Dalgleish Street
  • Thebarton, SA 5031
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Mar 31, 2017 Quarterly Report
CIK 0001194833
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: South Australia, Australia
Year of Inc. 1996
Employees 70 a/o Apr 17, 2017
Company Officers/Contacts
Deborah Rathjen CEO
Jack Moschakis Securities Counsel, Company Secretary Manager
Company Directors
Errol De Souza Chairman
Alan Fisher
Deborah Rathjen
Peter Turner
David Wilson
Service Providers
Accounting/Auditing Firm
Deloitte Touche Tohmatsu
Woodside Plaza Level 14
240 St Georges Tce
Perth, WA, 6000
Australia
 
Securities Counsel
Johnson Winter & Slattery
Level 9
211 Victoria Square
Adelaide, SA, 5000
Australia
 
Investor Relations Firm
Stern IR, Inc.
19 West 87th Street
Suite 400
New York, NY, 5000
United States
 
Company History
  • Sponsored for OTCQX by Cowen and Company, LLC on 3/2/2015.
BNOEF Security Details
Share Structure
Market Value1 $144,354,734 a/o Jun 21, 2017
Authorized Shares 481,182,446 a/o Oct 05, 2016
Outstanding Shares 481,182,446 a/o Oct 05, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record 478,355,418 a/o Apr 18, 2017
Non US Stock Exchange Listing
BNO - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 41,250 (75.53%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security